Post by
sunrize on May 29, 2018 12:38pm
Can someone explain the valuation?
How can Medmen be valued at $1.6 billion?
Why is Sunniva valued at $189 million?
I know the stock market is not always rational, but Sunniva has been publicly trading for 4+ months now and with all the developments and increasing revenues, how can it be valued at almost a tenth of Medmen?
Why, why, why?
Or is it just my continued bad luck that stocks I invest in stay undervalued while other stocks are market darlings?
Why, why, why?
PS: And I hope that Alan Bullshitstein guy on Seeking Alpha eats crow and shits bricks for the rest of his life. What a turd he is.
Comment by
GOTMONEY on May 29, 2018 12:48pm
I feel you, sunrize... I think we just need to wait a tiny bit longer. There are so many Sunniva-specific catalysts coming up. Next 1-3 months should be awesome.
Comment by
sunrize on May 29, 2018 12:54pm
This post has been removed in accordance with Community Policy
Comment by
URLaughable3 on May 29, 2018 2:55pm
Mainly because sunniva didnt magically add $600M to their $1B value after a Q of revs totalling $3M lol. Medmen is a joke and will crash hard, zero substance to that comps valuation. Investors buying in are toast.
Comment by
URLaughable3 on May 29, 2018 3:00pm
Mmen down $120M in cap as of 5.5 hrs of trading, i see that trend continuing below a $1B cap.. Sunniva on the other hand should be uptrending to that $1B by august/september with extracts and cali facility getting some bud rolling. Patients my man, ur in the right stock, just boarded early, no matter long term.